Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.
Functionalized micellar systems for cancer targeted drug delivery. Publishing Authors By Initials
Functionalized micellar systems for cancer targeted drug delivery. Journal Published:
PUBLICATION TYPE: Review
Journal: Pharmaceutical research
VOLUME: 24
Page Numbers: 1029-46
Journal Abbreviation: Pharm. Res.
ISSN: 0724-8741
DAY: 24
MONTH: 03
YEAR: 2007
Functionalized micellar systems for cancer targeted drug delivery. Information
Number of References: 129
LANGUAGE: eng
NlmUniqueID: 8406521
Functionalized micellar systems for cancer targeted drug delivery. Keywords Mesh Terms:
KEYWORDS: Polymers
MESH TERMS: pharmacokinetics
Chemical & Substance for Abstract: Functionalized micellar systems for cancer targeted drug delivery. Information
Substance Name: Polymers
Registry Number: 0
Grant and Affiliation Information for Functionalized micellar systems for cancer targeted drug delivery.
AFFILIATION: Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75390, USA. jinming.gao@utsouthwestern.edu
Country: United States
AGENCY: United States NIBIB
GRANT: R21-EB-005394
ACRONYM: EB
MEDLINETA: Pharm Res
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Functionalized micellar systems for cancer targeted drug delivery Related Publications